CG Oncology, Inc. Common stock (CGON) — Working Capital to Net Assets Ratio
CG Oncology, Inc. Common stock (CGON) has a Working Capital to Net Assets ratio of 96.8% as of December 2025. Working capital of $728.64 Million (current assets of $759.48 Million minus current liabilities of $30.84 Million) is measured against net assets of $752.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CGON cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CG Oncology, Inc. Common stock Working Capital to Net Assets (2021–2025)
This chart shows how CG Oncology, Inc. Common stock's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 96.8%, reflecting working capital of $728.64 Million against net assets of $752.60 Million USD. For the complete balance sheet picture, see CG Oncology, Inc. Common stock assets under control.
Annual Working Capital to Net Assets for CG Oncology, Inc. Common stock (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for CG Oncology, Inc. Common stock from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of CG Oncology, Inc. Common stock to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.8% | $728.64 Million | $752.60 Million | $759.48 Million | $30.84 Million | ▼ -3.1 pp |
| 2024 | 99.9% | $732.84 Million | $733.38 Million | $754.21 Million | $21.37 Million | ▲ +2.6 pp |
| 2023 | 97.3% | $179.87 Million | $184.79 Million | $194.12 Million | $14.25 Million | ▼ -7.9 pp |
| 2022 | 105.3% | $131.78 Million | $125.18 Million | $147.21 Million | $15.43 Million | ▼ -25.0 pp |
| 2021 | 130.3% | $52.43 Million | $40.25 Million | $58.41 Million | $5.97 Million | — |